C85.76 Other specified types of non-Hodgkin's lymphoma, intrapelvic lymph nodes

Name of the Condition

• Other specified types of non-Hodgkin's lymphoma, intrapelvic lymph nodes
• C85.76

Summary

Other specified types of non-Hodgkin's lymphoma, intrapelvic lymph nodes, is a subtype of non-Hodgkin lymphoma (NHL) involving the lymph nodes within the pelvic region. This code applies when the lymphoma type is known but not classified into a more specific subcategory, and the site of involvement is limited to intrapelvic lymph nodes. NHL arises from abnormal lymphocyte growth in the lymphatic system, which is part of the immune system.

Causes

The exact cause of this condition is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes in the pelvic area
• Pelvic pain or discomfort
• Abdominal fullness or bloating
• Unexplained weight loss
• Fever, night sweats, or fatigue

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI scans) to identify lymph node involvement, and biopsy of the affected tissue to confirm lymphoma type. Blood tests and additional imaging may be used to assess disease extent. Documentation should specify the lymphoma subtype and site to support accurate coding.

Treatment Options

Treatment depends on the lymphoma subtype, stage, and patient health. Options may include chemotherapy, immunotherapy, radiation therapy, or targeted therapy. Treatment plans are individualized and may involve a multidisciplinary team to address specific needs.

Prognosis and Follow-Up

Prognosis varies based on factors like lymphoma subtype, stage, and patient response to treatment. Regular follow-up with imaging and clinical assessments is important to monitor for recurrence or progression. Long-term surveillance may be recommended.

Complications

Potential complications include disease progression, treatment-related side effects (e.g., infection risk, organ toxicity), and lymphoma spread to other areas. Pelvic involvement may affect nearby structures, leading to functional or symptomatic issues.

Lifestyle & Prevention

While prevention is not always possible, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., excessive chemical exposure) may support overall health. Vaccinations and infection prevention are important for immunocompromised individuals.

When to Seek Professional Help

Seek medical attention for persistent pelvic symptoms, unexplained weight loss, fever, or night sweats. Early evaluation is crucial for timely diagnosis and management.

Tips for Medical Coders

Use C85.76 when the condition is documented as non-Hodgkin's lymphoma with involvement of intrapelvic lymph nodes, and the subtype is specified but not classified under a more precise code. Ensure documentation clearly identifies the site (intrapelvic lymph nodes) and confirms the lymphoma type to support accurate coding.